PDF) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. (2005) | Giampaolo Bucaneve | 521 Citations
Untitled
Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
Ferrata Storti Foundation
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases
IJMS | Free Full-Text | Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose ...
Prof.ssa Giorgina Specchia, ematologo - Prenota online | MioDottore.it
Giorgina SPECCHIA | Research profile
Ferrata Storti Foundation
IJMS | Free Full-Text | TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
Ruxolitinib – better prognostic impact in low-intermediate 1 risk score: evaluation of the 'rete ematologica pugliese' (RE
PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu
Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients
CODICE CONCORSO 2019POR023 PROCEDURA VALUTATIVA DI CHIAMATA PER LA COPERTURA DI N.1 POSTO DI PROFESSORE UNIVERSITARIO DI RUOLO D
JCM | Free Full-Text | The Role of Autoimmune Diseases in the Prognosis of Lymphoma
Untitled
Type of the Paper (Article
program outcome in follicular lymphomas treated with a rituximab-intensive Persistence of minimal residual disease in bone marro
V.LE LUIGI EINAUDI, 11/0 – 70125 339 1684398 [email protected] SPCGGN49L71I950A
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma
Prof.ssa Giorgina Specchia: ematologa a Bari
Prof.ssa Giorgina Specchia - Pianeta Salute
Nuova collaborazione con la prof.ssa Giorgina Specchia – CMP
